| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |